about
Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapyCarotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinomaSparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.Unraveling the molecular genetics of head and neck cancer through genome-wide approachesPatients with low lying lymph nodes are at high risk for distant metastasis in oropharyngeal cancer.Radiation therapy in the treatment of minor salivary gland tumors.Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.Interactive semiautomatic contour delineation using statistical conditional random fields frameworkPalliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.Dose-volume factors correlating with trismus following chemoradiation for head and neck cancerPatterns of regional and distant metastasis in esthesioneuroblastoma.Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinomaHypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experiencePercutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapyIrradiation for locoregionally recurrent, never-irradiated oral cavity cancers.Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience.Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and NeckThe relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positA nomogram to predict loco-regional control after re-irradiation for head and neck cancer.Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC).Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.Delivering a third course of radiation to spine metastases using image-guided, intensity-modulated radiation therapy.A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy.Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.The role of neoantigens in response to immune checkpoint blockade.Proton therapy for head and neck cancer: expanding the therapeutic window.Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers.Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma.The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaMultiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer.Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy.The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
P50
Q26863511-2EA7E604-6FDF-49D7-803E-9A848DCD4990Q33900752-82CF3BFB-31CF-43DF-BE5D-692193A1D6ECQ33900763-B8FB624E-1FDC-4EF1-853F-1005CF402627Q33908290-9B50AF76-E145-4AC1-B4A3-3E3991263356Q35025009-D162E412-3BBF-4B42-A5F5-B3C1E838DFF8Q35209854-8A9FF2B9-0CBB-4907-BA2A-D7C6911E1EE7Q35841958-08B5EA1D-C9B0-4CDF-8795-F9803EB67F1CQ35943671-13AFA132-AFEA-49FA-9406-86F24EF4062CQ36142305-20E8550F-1248-4E11-BED0-4D47C2DF5428Q36593737-F97C39B0-5526-44CC-B735-0A75F3293AECQ36668288-80BF8977-7BB8-4AA5-83C6-751B891DE39DQ37022584-25649657-F7E3-4694-9E37-A3ED2B632028Q37052331-0F5FC17F-1AA6-4D67-AA60-D727F4F94BB5Q37083138-593678FC-8CC0-4AC7-BD18-22DBFC136879Q37143286-BE465B37-C52B-408B-B689-AA91D5F165ADQ37151652-D52A7782-B3E2-49AF-8D6E-115CC3B605DDQ37156582-4612E9B2-387E-4A78-A26A-8603D5B4CDAFQ37156590-00CD8D9C-94C2-478B-A25B-6F5B0EEF30DAQ37163131-E8DF8FF8-1BA0-4770-A0B2-696ECE53F3D6Q37192658-6C80D061-F4D4-4147-AD49-2449EE38B0E8Q37445514-692C400A-2B59-42A8-8A99-9FF90C1838C2Q37446330-74D8310A-80EE-4A83-B847-59A8B138A2E0Q37705828-897FDE76-66CA-4E34-9FAE-218E6B87F39FQ37713795-528D732A-AD39-4617-9453-CE01BFBF7869Q37717953-3A14A2BE-3931-477A-9F7D-F4871C922202Q38055835-2B04581D-5B9F-4FBC-B251-4918BC668401Q38257116-5C5DA858-DB10-44CE-BFAE-274879FF5ECBQ38284473-9849EF68-D28C-4DAB-88B2-ED2290FC285BQ38403311-F0964FEE-78C0-4604-8715-CA27EFE11FA2Q38764833-B3A50082-7D0D-4FEC-84CE-7BBCD985BC4CQ38798968-BC890A57-F6DB-4C24-BFC2-1EF06FA759A1Q38812787-F2462BB4-0AD6-4A0C-97CE-20D72CBB7B57Q38872869-82378823-83DF-4C28-8D4A-F42FAFA12D1CQ38903318-EB031BAC-29A0-44D4-A95B-286B441BC7D1Q38904371-94A3C9DB-911D-456F-A94F-EB44726D29DAQ38924379-B17A5CFB-8A42-40ED-8350-782FDCE9164AQ38968830-506EC92A-268D-4963-8EA5-0B2261447396Q39926027-C67002D9-E7AF-42CC-98DD-F6F8C5164C55Q40337652-D82B71FE-35CF-48A4-9A6D-63CCF5BC5AE6Q40421093-941D7BC7-EE0B-489B-B8F1-F208BA26AF3A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Nadeem Riaz
@en
Nadeem Riaz
@nl
type
label
Nadeem Riaz
@en
Nadeem Riaz
@nl
prefLabel
Nadeem Riaz
@en
Nadeem Riaz
@nl
P31
P496
0000-0001-9873-5862